Literature DB >> 23169768

Single-blind randomized controlled trial of surfactant vs hypertonic saline irrigation following endoscopic endonasal surgery.

Alexander A Farag1, Allison M Deal, Kibwei A McKinney, Brian D Thorp, Brent A Senior, Charles S Ebert, Adam M Zanation.   

Abstract

BACKGROUND: Recent discussion has revolved around formulations of irrigation in the postoperative functional endoscopic sinus surgery patient, specifically the efficacy of emulsion based nasal irrigations.
METHODS: Forty adult candidates for endoscopic endonasal surgery with chronic rhinosinusitis (CRS) were prospectively randomized. The 22-item Sino-Nasal Outcome Test (SNOT-22) and 31-item Rhinosinusitis Outcome Measure (RSOM-31) quality of life assessments, as well as a phenyl ethyl alcohol (PEA) smell threshold test were obtained preoperatively and over 3 postoperative visits in a 4-month period. Repeated measures analyses and Fisher's exact tests were used to assess statistical differences.
RESULTS: Of the 40 patients enrolled, 33, 32, and 26 patients were seen at postoperative visits 1, 2, and 3, respectively. The surfactant (S) and hypertonic saline (HS) irrigation groups both showed significant decreases in scores for both the SNOT-22 and RSOM-31 over time (both p < 0.0001), but no difference was seen between the 2 groups (p = 0.09, p = 0.5). PEA thresholds showed overall improvement in both groups 3 to 4 months after surgery: 62% (8/13) of HS patients and 50% (6/12) of S patients, but did not differ between the groups (p = 0.3). The S group reported significantly more side effects (52% vs 6%, p = 0.002) and had more patients stop the solution (20% vs 0%) and fewer S patients finished the study compared to the HS group.
CONCLUSION: There were no significant differences in overall subjective symptoms related to sinonasal disease between S and HS irrigation, but tolerability appeared to be an issue. More patients reported side effects with S irrigation, and 20% receiving S irrigation stopped the solution, compared to none receiving HS irrigation.
© 2013 ARS-AAOA, LLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169768     DOI: 10.1002/alr.21116

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  9 in total

Review 1.  A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).

Authors:  M Mahdavinia; A Keshavarzian; M C Tobin; A L Landay; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

2.  Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations.

Authors:  R D Divekar; S Samant; M A Rank; J Hagan; D Lal; E K O'Brien; H Kita
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

Review 3.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

4.  Biofilms and inflammation in patients with chronic rhinosinusitis.

Authors:  Lavinia-Gianina Manciula; Ionut Isaia Jeican; Lucian Barbu Tudoran; Silviu Albu
Journal:  Med Pharm Rep       Date:  2020-10-25

Review 5.  Surfactants in the management of rhinopathologies.

Authors:  Philip L Rosen; James N Palmer; Bert W O'Malley; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

Review 6.  Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).

Authors:  Victor B Hsue; Kyohei Itamura; Arthur W Wu; Elisa A Illing; Kevin J Sokoloski; Bree A Weaver; Benjamin P Anthony; Nathan Hughes; Jonathan Y Ting; Thomas S Higgins
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Clinical Practice Guideline: Nasal Irrigation for Chronic Rhinosinusitis in Adults.

Authors:  Do-Yang Park; Ji Ho Choi; Dong-Kyu Kim; Yong Gi Jung; Sue Jean Mun; Hyun Jin Min; Soo Kyoung Park; Jae-Min Shin; Hyung Chae Yang; Seung-No Hong; Ji-Hun Mo
Journal:  Clin Exp Otorhinolaryngol       Date:  2022-02-15       Impact factor: 3.372

Review 8.  Acupuncture for the Treatment of Chronic Rhinosinusitis: A PRISMA-Compliant Systematic Review and Meta-Analysis.

Authors:  Boram Lee; Chan-Young Kwon; Man Young Park
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-31       Impact factor: 2.650

Review 9.  Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies.

Authors:  Judd H Fastenberg; Wayne D Hsueh; Ali Mustafa; Nadeem A Akbar; Waleed M Abuzeid
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-05-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.